Cardiogenesis Corporation to Report 2008 Fourth Quarter and Year-End Results on March 31st
2009年3月4日 - 9:30PM
PRニュース・ワイアー (英語)
IRVINE, Calif., March 4 /PRNewswire-FirstCall/ -- Cardiogenesis
Corporation (Pink Sheets: CGCP), announced that the company will
release results for its fourth quarter and full year ended December
31, 2008 prior to market open on Tuesday, March 31, 2009. The
company also said that President Richard P. Lanigan and Senior Vice
President and Chief Financial Officer William R. Abbott will host
an investor conference call that day at 12:00 p.m. Eastern time
(9:00 a.m. Pacific time) to review the company's financial results
and business outlook. The call is open to all interested investors
through a live audio web broadcast via the Internet at
http://www.cardiogenesis.com/ and will also be available by dialing
(800) 706-7745. The participant passcode is 47828764. The call will
be archived on the company's web site and will be available for
playback for seven days beginning shortly after the live webcast.
About Cardiogenesis Corporation Cardiogenesis is a medical device
company specializing in the treatment of cardiovascular disease and
is a leader in devices that stimulate cardiac angiogenesis. The
company's market leading Holmium:YAG laser system and disposable
fiber-optic accessories are used to perform a FDA-cleared surgical
procedure known as Transmyocardial Revascularization (TMR) to treat
patients suffering from angina. Surgical products and accessories
for the Cardiogenesis TMR procedure, which are marketed in the U.S.
and around the world, have been shown to reduce angina and improve
the quality of life in patients with coronary artery disease. For
more information on the company and its products, please visit the
Cardiogenesis company website at http://www.cardiogenesis.com/ or
the direct to patient website at http://www.heartofnewlife.com/.
DATASOURCE: Cardiogenesis Corporation CONTACT: William R. Abbott,
Senior Vice President and Chief Financial Officer of Cardiogenesis
Corporation, +1-949-420-1800 Web Site:
http://www.cardiogenesis.com/
Copyright